Ariad Pharmaceuticals (ARIA) 7.35 $ARIA
Can Radius Health (RDUS) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 9:06AM CST
Radius Health, Inc. (RDUS) is expected to report its fourth-quarter and full-year 2014 results on Feb 16 and carries an Earnings ESP of +5.00%.
RDUS: 50.37 (+0.63), IPXL: 39.51 (+0.69), ACT: 285.37 (+3.71), ARIA: 7.35 (+0.45)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 8:15AM CST
CYTK: 7.78 (+1.29), HK: 2.18 (-0.02), CYBR: 52.52 (+6.83), FXEN: 1.99 (+0.10), NBG: 1.61 (+0.18), MBT: 10.36 (+0.62), SDRL: 12.32 (-0.70), MTSN: 4.04 (+0.19), BLDP: 2.66 (-0.26), GDP: 3.58 (+0.29), REXX: 5.08 (+0.13), DNR: 8.66 (+0.39), ZNGA: 2.24 (-0.42), KING: 16.70 (+1.96), SD: 2.09 (+0.14), MX: 7.52 (-7.50), KN: 18.59 (-3.05), GENE: 8.04 (+1.90), VDSI: 27.86 (+2.69), IDRA: 4.10 (-0.14), SFY: 2.91 (+0.26), ARIA: 7.35 (+0.45), FSL: 37.53 (+2.83), PRAN: 1.09 (-0.55), OAS: 16.84 (-0.03)
What's New in the Pharma Sector: New Research on Amgen, Applied Genetic Technologies, Aptose, ARIAD, and Atara Biotherapeutics
PR Newswire - Fri Feb 13, 6:40AM CST
Editor Note: For more information about this release, please scroll to bottom.
AGTC: 24.49 (-0.19), APTO: 4.65 (+0.43), AMGN: 153.48 (+0.30), ATRA: 18.00 (-0.10), ARIA: 7.35 (+0.45)
Ariad +4.1%; activist reportedly wants CEO change
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 5:02PM CST
ARIA: 7.35 (+0.45)
ARIAD to Present at the RBC Capital Markets' Healthcare Conference
Business Wire - Wed Feb 11, 6:35AM CST
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that it will present at the RBC Capital Markets' Healthcare Conference being held in New York City. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company's business on Wednesday, February 25, at 8:00 a.m. (ET).
ARIA: 7.35 (+0.45)
Will Immune Design (IMDZ) Miss on Earnings This Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 1:40PM CST
Immune Design (IMDZ) is expected to report fourth-quarter 2014 results on Feb 11, 2015 and holds a Zacks Rank #4 (Sell) with an Earnings ESP of 0.00%.
IMDZ: 25.34 (+1.20), ACT: 285.37 (+3.71), ARIA: 7.35 (+0.45), SNY: 49.42 (+0.82)
Will Ligand Pharmaceuticals (LGND) Miss on Earnings in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:54AM CST
Ligand Pharmaceuticals (LGND) is scheduled to report fourth-quarter 2014 results on Feb 9, 2015 and holds a Zacks Rank #3 (Hold) with Earnings ESP of -4.17%.
ACT: 285.37 (+3.71), LGND: 55.91 (-0.35), SPPI: 7.20 (+0.15), ARIA: 7.35 (+0.45)
Critical Alerts For LinkedIn, Ariad Pharmaceuticals, Tableau Software, Nu Skin Enterprises and CBS Released By InvestorsObserver
PR Newswire - Fri Feb 06, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for LNKD, ARIA, DATA, NUS and CBS.
LNKD: 269.00 (+1.83), NUS: 56.92 (-1.30), ARIA: 7.35 (+0.45), DATA: 99.90 (+1.40), CBS: 59.83 (+2.06)
Biotech Stocks Scanner - ARIAD Pharma, Celgene, CytRx, Amicus Therapeutics, and United Therapeutics
PR Newswire - Wed Feb 04, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Celgene Corporation (NASDAQ: CELG), CytRx Corporation (NASDAQ: CYTR), Amicus Therapeutics Inc. (NASDAQ: FOLD), and United Therapeutics Corporation (NASDAQ: UTHR). Free research report on ARIAD Pharma can be accessed at http://get.Investor-Edge.com/pdf/?c=ARIAD%20P...amp;s=ARIA. On Tuesday, February 03, 2015, the NASDAQ Composite ended at 4,727.74, up 1.09%, the Dow Jones Industrial Average advanced 1.76%, to finish the day at 17,666.40, and the S&P 500 closed at 2,050.03, up 1.44%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 811.48, up 0.65%, with the index also advancing 4.16% in the previous three months. Register for your complimentary reports at the links given below.
UTHR: 151.11 (+3.59), CYTR: 2.96 (+0.23), ARIA: 7.35 (+0.45), FOLD: 8.36 (-0.11), CELG: 115.88 (+0.16), CELGZ: 3.17 (-0.04)
ARIAD to Present at the Leerink Global Healthcare Conference
Business Wire - Tue Feb 03, 6:35AM CST
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Leerink Global Healthcare Conference being held in New York City. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company's business on Thursday, February 12, at 3:30 p.m. (ET).
ARIA: 7.35 (+0.45)
Will Pacific Biosciences (PACB) Surprise on Earnings in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 3:40PM CST
Pacific Biosciences of California, Inc. (PACB) has an earnings ESP of 0.00% and is scheduled to report fourth-quarter 2014 results on Feb 3, 2015 after the market closes.
ACT: 285.37 (+3.71), PACB: 6.96 (-0.06), ARIA: 7.35 (+0.45), REGN: 402.40 (+0.66)
Will GW Pharmaceuticals (GWPH) Miss this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 1:40PM CST
GW Pharmaceuticals (GWPH), which is scheduled to report first-quarter fiscal 2015 results on Feb 4, had delivered a positive earnings surprise of 104.35% in the last quarter.
ACT: 285.37 (+3.71), GWPH: 78.09 (+1.70), ARIA: 7.35 (+0.45), REGN: 402.40 (+0.66)
3 Biotechs Looking Good this Earnings Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Fri Jan 30, 11:38AM CST
A number of biotech companies are seeing improvements in their financial results.
BCRX: 10.06 (-0.09), PCYC: 163.28 (+0.23), ARIA: 7.35 (+0.45)
ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2014 Financial Results
Business Wire - Thu Jan 29, 6:35AM CST
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its fourth quarter and year-end 2014 financial results and issue 2015 financial guidance on Thursday, February 19, 2015, before the market opens. Following the announcement, at 8:30 a.m. Eastern Time, company management will host a conference call and webcast discussion of the results and provide a general corporate update.
ARIA: 7.35 (+0.45)
ARIAD: The Worst May Not Be Over
Value Insight - at Seeking Alpha - Wed Jan 28, 10:15AM CST
ARIA: 7.35 (+0.45)
ARIAD Pharmaceuticals (ARIA) Flagged As Strong On High Volume
at The Street - Wed Jan 28, 9:01AM CST
Trade-Ideas LLC identified ARIAD Pharmaceuticals (ARIA) as a strong on high relative volume candidate
ARIA: 7.35 (+0.45)
InsiderInsights.com Daily Round Up 1/26/15: THRM, FXCM, OPK, TCBI
InsiderInsights - at Seeking Alpha - Wed Jan 28, 3:00AM CST
AZZ: 44.86 (+0.22), IGTE: 39.53 (+0.62), BALT: 1.74 (+0.09), EGBN: 36.43 (-0.31), FXCM: 2.21 (-0.01), TCBI: 48.51 (+0.81), THRM: 41.21 (+0.38), VEEV: 30.12 (+0.17), VSAR: 18.04 (-0.55), PN: 13.35 (-0.14), LNKD: 269.00 (+1.83), OPK: 13.80 (-0.28), NERV: 4.68 (+0.09), CAS: 6.14 (-0.01), SGNT: 27.75 (-0.41), ARIA: 7.35 (+0.45), TWTR: 48.50 (+0.55), BKE: 49.59 (-0.16)
Earnings Peek: ARIAD Should Easily Beat Outdated Estimates
Clinically Sound Investor - at Seeking Alpha - Tue Jan 27, 1:19PM CST
ARIA: 7.35 (+0.45)
Insider Trading Alerts for FXCM, Achillion Pharmaceuticals, Ariad Pharmaceuticals, Kinder Morgan, Twitter, and Yahoo
PR Newswire - Tue Jan 27, 7:45AM CST
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: FXCM (NYSE:FXCM), Achillion Pharmaceuticals (NASDAQ:ACHN), Ariad Pharmaceuticals (NASDAQ:ARIA), Kinder Morgan (NYSE:KMI), Twitter (NYSE:TWTR), and Yahoo! (NASDAQ:YHOO).
KMI: 41.97 (+0.21), YHOO: 44.42 (+0.50), ACHN: 10.89 (-0.20), ARIA: 7.35 (+0.45), FXCM: 2.21 (-0.01), TWTR: 48.50 (+0.55)
Seeking Alpha's Biotech Weekly: Salix Sale Murmurs, A Very Active CHMP, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Jan 23, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
CRIS: 3.23 (+0.25), NAVB: 1.60 (unch), TROV: 4.99 (-0.17), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), ABBV: 58.05 (+1.00), ARIA: 7.35 (+0.45), ARNA: 4.55 (+0.02), REGN: 402.40 (+0.66), NVS: 102.20 (-0.17)
Can Radius Health (RDUS) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 9:06AM CST
Radius Health, Inc. (RDUS) is expected to report its fourth-quarter and full-year 2014 results on Feb 16 and carries an Earnings ESP of +5.00%.
RDUS: 50.37 (+0.63), IPXL: 39.51 (+0.69), ACT: 285.37 (+3.71), ARIA: 7.35 (+0.45)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 8:15AM CST
CYTK: 7.78 (+1.29), HK: 2.18 (-0.02), CYBR: 52.52 (+6.83), FXEN: 1.99 (+0.10), NBG: 1.61 (+0.18), MBT: 10.36 (+0.62), SDRL: 12.32 (-0.70), MTSN: 4.04 (+0.19), BLDP: 2.66 (-0.26), GDP: 3.58 (+0.29), REXX: 5.08 (+0.13), DNR: 8.66 (+0.39), ZNGA: 2.24 (-0.42), KING: 16.70 (+1.96), SD: 2.09 (+0.14), MX: 7.52 (-7.50), KN: 18.59 (-3.05), GENE: 8.04 (+1.90), VDSI: 27.86 (+2.69), IDRA: 4.10 (-0.14), SFY: 2.91 (+0.26), ARIA: 7.35 (+0.45), FSL: 37.53 (+2.83), PRAN: 1.09 (-0.55), OAS: 16.84 (-0.03)
What's New in the Pharma Sector: New Research on Amgen, Applied Genetic Technologies, Aptose, ARIAD, and Atara Biotherapeutics
PR Newswire - Fri Feb 13, 6:40AM CST
Editor Note: For more information about this release, please scroll to bottom.
AGTC: 24.49 (-0.19), APTO: 4.65 (+0.43), AMGN: 153.48 (+0.30), ATRA: 18.00 (-0.10), ARIA: 7.35 (+0.45)
Ariad +4.1%; activist reportedly wants CEO change
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 5:02PM CST
ARIA: 7.35 (+0.45)
ARIAD to Present at the RBC Capital Markets' Healthcare Conference
Business Wire - Wed Feb 11, 6:35AM CST
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that it will present at the RBC Capital Markets' Healthcare Conference being held in New York City. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company's business on Wednesday, February 25, at 8:00 a.m. (ET).
ARIA: 7.35 (+0.45)
Will Immune Design (IMDZ) Miss on Earnings This Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 1:40PM CST
Immune Design (IMDZ) is expected to report fourth-quarter 2014 results on Feb 11, 2015 and holds a Zacks Rank #4 (Sell) with an Earnings ESP of 0.00%.
IMDZ: 25.34 (+1.20), ACT: 285.37 (+3.71), ARIA: 7.35 (+0.45), SNY: 49.42 (+0.82)
Will Ligand Pharmaceuticals (LGND) Miss on Earnings in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:54AM CST
Ligand Pharmaceuticals (LGND) is scheduled to report fourth-quarter 2014 results on Feb 9, 2015 and holds a Zacks Rank #3 (Hold) with Earnings ESP of -4.17%.
ACT: 285.37 (+3.71), LGND: 55.91 (-0.35), SPPI: 7.20 (+0.15), ARIA: 7.35 (+0.45)
Critical Alerts For LinkedIn, Ariad Pharmaceuticals, Tableau Software, Nu Skin Enterprises and CBS Released By InvestorsObserver
PR Newswire - Fri Feb 06, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for LNKD, ARIA, DATA, NUS and CBS.
LNKD: 269.00 (+1.83), NUS: 56.92 (-1.30), ARIA: 7.35 (+0.45), DATA: 99.90 (+1.40), CBS: 59.83 (+2.06)
Biotech Stocks Scanner - ARIAD Pharma, Celgene, CytRx, Amicus Therapeutics, and United Therapeutics
PR Newswire - Wed Feb 04, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Celgene Corporation (NASDAQ: CELG), CytRx Corporation (NASDAQ: CYTR), Amicus Therapeutics Inc. (NASDAQ: FOLD), and United Therapeutics Corporation (NASDAQ: UTHR). Free research report on ARIAD Pharma can be accessed at http://get.Investor-Edge.com/pdf/?c=ARIAD%20P...amp;s=ARIA. On Tuesday, February 03, 2015, the NASDAQ Composite ended at 4,727.74, up 1.09%, the Dow Jones Industrial Average advanced 1.76%, to finish the day at 17,666.40, and the S&P 500 closed at 2,050.03, up 1.44%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 811.48, up 0.65%, with the index also advancing 4.16% in the previous three months. Register for your complimentary reports at the links given below.
UTHR: 151.11 (+3.59), CYTR: 2.96 (+0.23), ARIA: 7.35 (+0.45), FOLD: 8.36 (-0.11), CELG: 115.88 (+0.16), CELGZ: 3.17 (-0.04)
ARIAD to Present at the Leerink Global Healthcare Conference
Business Wire - Tue Feb 03, 6:35AM CST
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Leerink Global Healthcare Conference being held in New York City. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company's business on Thursday, February 12, at 3:30 p.m. (ET).
ARIA: 7.35 (+0.45)
Will Pacific Biosciences (PACB) Surprise on Earnings in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 3:40PM CST
Pacific Biosciences of California, Inc. (PACB) has an earnings ESP of 0.00% and is scheduled to report fourth-quarter 2014 results on Feb 3, 2015 after the market closes.
ACT: 285.37 (+3.71), PACB: 6.96 (-0.06), ARIA: 7.35 (+0.45), REGN: 402.40 (+0.66)
Will GW Pharmaceuticals (GWPH) Miss this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 1:40PM CST
GW Pharmaceuticals (GWPH), which is scheduled to report first-quarter fiscal 2015 results on Feb 4, had delivered a positive earnings surprise of 104.35% in the last quarter.
ACT: 285.37 (+3.71), GWPH: 78.09 (+1.70), ARIA: 7.35 (+0.45), REGN: 402.40 (+0.66)
3 Biotechs Looking Good this Earnings Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Fri Jan 30, 11:38AM CST
A number of biotech companies are seeing improvements in their financial results.
BCRX: 10.06 (-0.09), PCYC: 163.28 (+0.23), ARIA: 7.35 (+0.45)
ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2014 Financial Results
Business Wire - Thu Jan 29, 6:35AM CST
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its fourth quarter and year-end 2014 financial results and issue 2015 financial guidance on Thursday, February 19, 2015, before the market opens. Following the announcement, at 8:30 a.m. Eastern Time, company management will host a conference call and webcast discussion of the results and provide a general corporate update.
ARIA: 7.35 (+0.45)
ARIAD: The Worst May Not Be Over
Value Insight - at Seeking Alpha - Wed Jan 28, 10:15AM CST
ARIA: 7.35 (+0.45)
ARIAD Pharmaceuticals (ARIA) Flagged As Strong On High Volume
at The Street - Wed Jan 28, 9:01AM CST
Trade-Ideas LLC identified ARIAD Pharmaceuticals (ARIA) as a strong on high relative volume candidate
ARIA: 7.35 (+0.45)
InsiderInsights.com Daily Round Up 1/26/15: THRM, FXCM, OPK, TCBI
InsiderInsights - at Seeking Alpha - Wed Jan 28, 3:00AM CST
AZZ: 44.86 (+0.22), IGTE: 39.53 (+0.62), BALT: 1.74 (+0.09), EGBN: 36.43 (-0.31), FXCM: 2.21 (-0.01), TCBI: 48.51 (+0.81), THRM: 41.21 (+0.38), VEEV: 30.12 (+0.17), VSAR: 18.04 (-0.55), PN: 13.35 (-0.14), LNKD: 269.00 (+1.83), OPK: 13.80 (-0.28), NERV: 4.68 (+0.09), CAS: 6.14 (-0.01), SGNT: 27.75 (-0.41), ARIA: 7.35 (+0.45), TWTR: 48.50 (+0.55), BKE: 49.59 (-0.16)
Earnings Peek: ARIAD Should Easily Beat Outdated Estimates
Clinically Sound Investor - at Seeking Alpha - Tue Jan 27, 1:19PM CST
ARIA: 7.35 (+0.45)
Insider Trading Alerts for FXCM, Achillion Pharmaceuticals, Ariad Pharmaceuticals, Kinder Morgan, Twitter, and Yahoo
PR Newswire - Tue Jan 27, 7:45AM CST
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: FXCM (NYSE:FXCM), Achillion Pharmaceuticals (NASDAQ:ACHN), Ariad Pharmaceuticals (NASDAQ:ARIA), Kinder Morgan (NYSE:KMI), Twitter (NYSE:TWTR), and Yahoo! (NASDAQ:YHOO).
KMI: 41.97 (+0.21), YHOO: 44.42 (+0.50), ACHN: 10.89 (-0.20), ARIA: 7.35 (+0.45), FXCM: 2.21 (-0.01), TWTR: 48.50 (+0.55)
Seeking Alpha's Biotech Weekly: Salix Sale Murmurs, A Very Active CHMP, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Jan 23, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
CRIS: 3.23 (+0.25), NAVB: 1.60 (unch), TROV: 4.99 (-0.17), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), ABBV: 58.05 (+1.00), ARIA: 7.35 (+0.45), ARNA: 4.55 (+0.02), REGN: 402.40 (+0.66), NVS: 102.20 (-0.17)
